Neoplastic effect of vinyl chloride in mouse lung - lower doses and short-term exposure.
Authors
Suzuki Y
Source
Mount Sinai School of Medicine, New York New York, 1982 Jan; :1-27
Link
NIOSHTIC No.
00134961
Abstract
The neoplastic pulmonary effects of vinyl-chloride (75014) (VC) were studied in mice. Male CD1-mice were exposed to VC vapor at concentrations of 2500 or 6000 parts per million (ppm) for 5 to 6 months. Animals were then killed and studied for histopathological changes. CD1-mice were exposed to 0.1, 10, 100, 300, or 600ppm VC for 4 weeks and were observed for at least 41 weeks. Animals were killed at intervals up to 41 weeks after exposure and lungs were studied for histopathological changes. Ninety six percent of the mice exposed to 2500 or 600ppm VC developed pulmonary tumors. These tumors were alveologenic and were characterized by large irregularly shaped mitochondria, tight junctions between adjacent cells, and lack of mucinous secretory granules and cilia. In mice exposed to VC for 4 weeks, the tumor incidence was 5 percent at 1ppm, 16 percent at 10ppm, 37.5 percent at 100ppm, 68.4 percent at 300ppm, and 92 percent at 600ppm. Induction times of the tumors was also dose related, ranging from 10 weeks at 600ppm to 40 weeks at 1, 10, and 100ppm. The author concludes that alveologenic tumors arose as a result of a transformation of type II epithelium through a hyperplastic form.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.